Trade Opportunity
Export Biotech from France to Greece under the EU-Mercosur Agreement 2026. Reduced tariffs and preferential access to a market of 780 million consumers.
📌 Why This Matters
Businesses can now access preferential treatment for their products.
💰 Cost Savings: Average tariff reduction of 35% on industrial goods.
🔗 Related Opportunities
📌 Why This Matters
Businesses can now access preferential treatment for their products.
📊 Key Statistics: Combined GDP of €18 trillion, bilateral trade worth €140 billion annually.